Evidence map›Paper›PMID 37784089›Full record

ArticleCell & bioscience2023

CD24

Wei-Jian Huang, Bi-Jun Qiu, Xiao-Shu Qi, Cai-Yang Chen, Wen-Ming Liu, Shen-Ao Zhou, Min Ding, Feng-Feng Lu, Jie Zhao, Dan Tang and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell & bioscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Resident CD24Acta biochimica et biophysica Sinica · 2025
    Article
  7. Article
  8. Lipocalin-2 and intestinal diseases.World journal of gastroenterology · 2024
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Wei-Jian Huang *Department of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Bi-Jun Qiu *Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University., Shanghai, China.
Xiao-Shu Qi *Department of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Cai-Yang Chen *Department of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Wen-Ming LiuDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Shen-Ao ZhouCelliver Biotechnology Inc., Shanghai, China.
Min DingDepartment of Interventional Oncology, Renji Hospital, School of Medicine, Jiaotong University, Shanghai, China.
Feng-Feng LuInstitute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Jie ZhaoDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University., Shanghai, China.
Dan TangDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Xu ZhouDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Gong-Bo FuDepartment of Medical Oncology, First School of Clinical Medicine, Jinling Hospital, Southern Medical University, Nanjing, China.
Zhen-Yu WangState Key Laboratory of Oncogenes and Related Genes, School of Medicine, Renji Hospital, Shanghai Cancer Institute, Shanghai Jiaotong University, Shanghai, China.
Hong-Qian MaDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Yu-Ling WuDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Hong-Ping WuInternational Cooperation Laboratory On Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Xiao-Song ChenDepartment of Infectious Diseases, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200120, China. chenxiaosong@renji.com.
Wei-Feng YuDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China. ywf808@yeah.net.
He-Xin YanDepartment of Anesthesiology and Critical Care Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200120, China. hexinyw@163.com.ORCID http://orcid.org/0000-0001-8390-650X
Shanghai Jiao Tong University · CNRenji Hospital · CNSecond Military Medical University · CNShanghai East Hospital · CNSouthern Medical University · CN

Funding

National Key R&D Program 2018YFA0108200National Natural Science Foundation of China 82100671National Natural Science Foundation of China 82203378National Natural Science Foundation of China 82270635
6 · The paper itself

Abstract

backgroundCD24

resultsThe current study combined genetic lineage tracing with in vitro small-molecule-based reprogramming to define liver progenitor cells (LPCs) derived from hepatic parenchymal and non-parenchymal tissues. tdTom

conclusionsCD24

Indexed as

Ductular reactionLCN2MacrophagesResident liver progenitor cellsSmall molecule cocktail

Identifiers

PMID37784089
PMCPMC10546777
OpenAlexW4387253918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.